CMV (CYTOMEGALOVIRUS) IGG AVIDITY

The CMV (Cytomegalovirus) IgG Avidity Test is a specialized blood test used to determine when a Cytomegalovirus (CMV) infection occurred. Unlike a standard CMV IgG antibody test, which only indicates previous exposure to the virus, the IgG Avidity Test measures the strength (avidity) with which IgG antibodies bind to the CMV antigen. This helps distinguish between a recent primary infection and a past infection.

CMV is a common virus belonging to the herpesvirus family. After the initial infection, the virus remains dormant in the body and may reactivate later, particularly in individuals with weakened immune systems. While CMV infection is usually mild in healthy adults, it can cause significant health concerns during pregnancy, as a primary infection may be transmitted to the unborn baby, resulting in congenital CMV infection.

The CMV IgG Avidity Test is particularly valuable when a pregnant woman has positive CMV IgM and IgG antibody results. In such cases, determining whether the infection is recent or occurred before pregnancy is crucial for assessing the risk to the fetus.

• Low IgG avidity generally suggests a recent primary CMV infection, usually within the previous 3–4 months.
• High IgG avidity generally indicates that the infection occurred more than 3–4 months earlier, making recent primary infection less likely.

The test is often performed alongside CMV IgG, CMV IgM, and CMV DNA PCR to provide a comprehensive evaluation of CMV infection.

Benefits of the Test

• Helps determine the timing of CMV infection
• Differentiates recent infection from past infection
• Supports pregnancy and prenatal CMV evaluation
• Assists in assessing congenital CMV risk
• Complements CMV IgG and IgM antibody testing
• Requires only a peripheral blood sample
• Supports informed clinical decision-making

Why Doctors Recommend This Test

Doctors may recommend this test for individuals with:

• Positive CMV IgM and IgG antibody results
• Pregnancy with suspected CMV infection
• Prenatal TORCH screening
• Suspected congenital CMV infection
• Immunocompromised conditions
• Organ transplant evaluation
• Unexplained viral illness requiring CMV assessment

Preparation Before Test

Sample Required

• Peripheral venous blood sample (Serum)

Preparation Guidelines

• No fasting is required.
• Continue prescribed medications unless advised otherwise by your physician.
• Inform your healthcare provider if you are pregnant, planning pregnancy, or have a weakened immune system.
• Follow laboratory instructions before sample collection.

Reporting Time

Results are generally available within 3–5 working days, depending on the laboratory methodology.

Who Should Take This Test?

This test is recommended for:

• Pregnant women with positive CMV IgM antibodies
• Women undergoing TORCH profile evaluation
• Individuals with suspected recent CMV infection
• Organ transplant recipients
• Immunocompromised patients
• Patients referred by obstetricians, infectious disease specialists, pediatricians, or physicians

Clinical Significance

The CMV IgG Avidity Test provides important information about the timing of infection:

• Low Avidity: Suggests a recent primary CMV infection, typically within the last few months.
• Intermediate Avidity: May require repeat testing or additional investigations.
• High Avidity: Indicates that infection most likely occurred several months earlier and reduces the likelihood of a recent primary infection.

This distinction is especially important during pregnancy because a primary CMV infection carries a higher risk of transmitting the virus to the fetus compared to reactivation of a previous infection.

The results should always be interpreted together with CMV IgM, CMV IgG, CMV DNA PCR, ultrasound findings (during pregnancy), and the patient's clinical history.